Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study

• Egile Nagusiak: Jie-Bin Lew, MPH (Egilea), Prof D James B St John, DMedSci (Egilea), Xiang-Ming Xu, MPH (Egilea), Marjolein J E Greuter, PhD (Egilea), Michael Caruana, DPhil (Egilea), Dayna R Cenin, MPH (Egilea), Emily He, MBBS MPH (Egilea), Marion Saville, MBChB (Egilea), Paul Grogan (Egilea), Veerle M H Coupé, PhD (Egilea), Prof Karen Canfell, DPhil (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2017-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: No assessment of the National Bowel Screening Program (NBCSP) in Australia, which considers all downstream benefits, costs, and harms, has been done. We aimed to use a comprehensive natural history model and the most recent information about cancer treatment costs to estimate long-term b...